Clincal Data Science

During PhUSE US Connect 2018 – the clinical data science conference – in Raleigh, North Carolina, MMS data science experts presented a paper and corresponding poster, titled Big Data Paradox: Development of a Unique and Repeatable Analytical Process while Implementing a Robust Data Science Solution.

Security and auditing: Data landing, storage, cleaning, standardization, analysis, prediction, and security

Authored by MMS experts Chris Hurley, Aditya Gadiko, Srinivas Mukkala, and Kulin Mehta, the paper’s abstract is as follows:

Who could have imagined that a few simple ASCII datasets would pose such a huge “big data” challenge? Therein lies the paradox, while the data is simple and there are relatively few variables to analyze, the volume is huge and presents a great processing challenge. This poster demonstrates a repeatable “big data” solution that utilizes FAERS data, provided quarterly by the FDA, to provide the answers to post-marketing safety surveillance questions. The process, techniques, and tools used to handle and analyze such massive amounts of data, in a clinical setting, are demonstrated here, creatively enabling us to cut the Gordian knot and overcome a seemingly impossible challenge.

To learn the robust clinical data science process behind this abstract, read the full paper here.

Suggested For You

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

perspectives

July 16th, 2024

Key Steps to Successful CMC Authoring of IND and IMPD Submissions

perspectives

July 9th, 2024

Managing RTOR Submissions: How to Run a Successful Race from the Top Line Starting Line

perspectives

July 2nd, 2024

Part 1: RWD Noninterventional Study Design and FDA Engagement Opportunity for Early Stage Oncology

perspectives

June 21st, 2024

Peer-Reviewed Journal Articles: The Crucial Role of Publication in the Pharmaceutical Industry

perspectives

June 14th, 2024

A Structured Approach to Benefit-Risk Assessment Throughout Product Development in the Pharmaceutical Industry

perspectives

June 6th, 2024

Datacise and Diversity in Patient Enrollment: Combining Geospatial and Demographic Data to Aid Site Selection

perspectives

May 29th, 2024

Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules

perspectives

May 21st, 2024

Psychedelics and Regulatory Considerations Part II: A Shift in Lexicon and Implications of “Nonmedical Use” On Labelling

perspectives

May 10th, 2024

Psychedelics in Drug Development and Regulatory Considerations Part I: Benefit-Risk

perspectives

April 29th, 2024

Validation of Clinical Dashboards for Decision Making